Logo

American Heart Association

  1
  0


Final ID: WP201

The Performance of Portable Low-field Magnetic resonance imaging in Acute Ischemic Stroke

Abstract Body: Introduction
The use of ultra low-field portable Magnetic Resonance Imaging (pMRI) in acute ischemic stroke (AIS) is gaining interest, as pMRI is FDA approved and has practical advantages over high-field MRI brain (hMRI). The ACTION PMR study is a prospective cohort study enrolling AIS and perform pMRI within 24 hours of last known normal (LKN). We sought to report patients enrolled in the study from our institution to evaluate the performance of pMRI compared to hMRI.

Methods
Among the 10 patients enrolled in our center, 1 was excluded for technically nondiagnostic imaging and 1 was excluded due to no infarct visible on hMRI, leaving 8 AIS patients in the cohort for analysis. All 8 patients had both pMRI and hMRI during their hospitalization. Our institutional pMRI (Hyperfine Inc. Swoop®) is a 0.064 Tesla MRI machine, and the protocol includes diffusion-weighted imaging, apparent diffusion coefficient, and fluid-attenuated inversion recovery (scan time 18 minutes) sequences. Infarct size was measured based upon maximum longitudinal axis on DWI.

Results
Among the 8 AIS patients with radiographic infarcts on hMRI, the mean age was 61.0 years (range, 47.2 to 76.2) and 2 were female. Thrombolysis was administered in 7 (87.5%) patients, and the mean NIHSS on presentation was 3.8 (range, 2 to 7). The mean time from LKN to pMRI was 15.9 hours (range, 10.9 to 20.3) and from pMRI to hMRI was 7.3 hours (range 1.2 to 17.6). All 8 AIS patients had infarcts visible on pMRI. On the 8 hMRI scans, 10 infarct lesions were demonstrated. Infarct distribution was as follows: subcortical (6), cerebellar (1), and cortical MCA/PCA (3). Among 10 infarct lesions measured, mean size was 15.2 mm (range 3.6 to 37.6), and 9 (90%) of hMRI infarcts were visible on pMRI, with the smallest infarct visible on pMRI being 4.5 mm. In contrast, the hMRI visible infarct that was not visible on pMRI measured 3.6 mm. Case 1 (Figure 1) demonstrated DWI-FLAIR mismatch of a right subcortical infarct on hMRI and on pMRI as well.

Conclusions
In our series, pMRI performed reasonably well on AIS patients and was able to detect the majority (90%) of acute infarcts seen on hMRI. pMRI was able to detect infarcts above 4.5 mm and was also able to demonstrate DWI-FLAIR mismatch. Clinicians need to be aware of the strengths and limitations of pMRI to maximize patient selection for use in the AIS population. Future improvements in DWI imaging at low field may improve sensitivity for small infarcts in the future.
  • Ciaramitaro, Cody  ( Ohio State University , Columbus , Ohio , United States )
  • Han, Alexander  ( Ohio State University , Columbus , Ohio , United States )
  • Nimjee, Shahid  ( Ohio State University , Columbus , Ohio , United States )
  • Forrest, Cassandra  ( Ohio State University , Columbus , Ohio , United States )
  • Sorby-adams, Annabel  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Kimberly, W. Taylor  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Lee, Vivien  ( Ohio State University , Columbus , Ohio , United States )
  • Author Disclosures:
    Cody Ciaramitaro: DO NOT have relevant financial relationships | Alexander Han: DO NOT have relevant financial relationships | Shahid Nimjee: DO have relevant financial relationships ; Speaker:Medtronic:Past (completed) ; Ownership Interest:Basking Biosciences:Active (exists now) ; Consultant:Cerenovus:Active (exists now) ; Consultant:Vesalio:Past (completed) | Cassandra Forrest: DO NOT have relevant financial relationships | Annabel Sorby-Adams: DO NOT have relevant financial relationships | W. Taylor Kimberly: DO have relevant financial relationships ; Researcher:Biogen:Past (completed) ; Consultant:Ji Xing Pharma:Active (exists now) ; Consultant:Astrocyte Pharma:Active (exists now) ; Consultant:Acasti Pharma:Active (exists now) ; Researcher:NControl Therapeutics:Past (completed) ; Researcher:Hyperfine Research, Inc:Active (exists now) | Vivien Lee: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Imaging Posters I

Wednesday, 02/05/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
Abdominal Aortic Blood Flow and Interstage Growth and Neurodevelopment in Patients with Single Ventricle Heart Disease

Abumregha Osama, Seed Mike, Floh Alejandro, Lee Fu-tsuen, Chetan Devin, Tedesco-bruce Anna, Herridge Joann, Gibson Erika, Honjo Osami, Sananes Renee, Ly Linh

A Real-World Pilot for Diagnostic Yield of Cardiac CTA vs Echocardiography in Acute Ischemic Stroke

Chakravarthula Nitin Ramanujam, Milani Marcus, Tessmer Megan, Staugaitis Abbey, Akimoto Kai, Markowitz Jeremy, Kalra Rajat, Nijjar Prabhjot, Streib Christopher

More abstracts from these authors:
Enhanced Stroke Detection with Multi-directional Diffusion Weighted Low-field Magnetic Resonance Imaging

Sorby-adams Annabel, Lee Vivien, Muir Keith, Nimjee Shahid, Rosen Matthew, Iglesias Juan Eugenio, Sheth Kevin, Kimberly W. Taylor, Pinter Nandor, Kirsch John, Jaikumar Vinay, Goldstein Joshua, Nelson Olivia, Bacchi Stephen, Guo Jennifer, Pitts Johns

Recanalization of intracranial vessel occlusion in Acute Ischemic Stroke and
Thrombolysis “Dwell Time”

Han Alexander, Forrest Cassandra, Ciaramitaro Cody, Nimjee Shahid, Lee Vivien

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)